All In Biotech

Drug Trial Radar · NCT02522338

Measurement of Glomerular Filtration Rate (GFR) in HIV Patients: Single-center Study Comparing the Accuracy of Estimators of GFR Versus Iohexol Plasma Clearance

Last checked: Nov 20, 2026Latest source record: Mar 10, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

300

Actual

Start

Feb 2011

Primary completion

Dec 2013

Study completion Dec 2013

Sponsor

Lead sponsor
Centre Hospitalier Universitaire de Saint EtienneAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 13, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Cystatin C, a protease inhibitor produced by most nucleated cells, is freely filtered by the kidneys, and its plasma assay reflects the GFR. Compare, in HIV patients, the predictive performance of 11 formula to estimate GFR based on assay plasma cystatin C with that of the MDRD formulas.

Conditions

  • HIV

Interventions

  • iohexolDrug

    10 ml de l'iohexol (300 mgI/ml)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Patient with a predictive performance range -30% to +30%Time frame: day 0

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • CHU de SAINT-ETIENNE

    Saint-Etienne, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.